CIK 0001374339
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
ProMIS Neurosciences Inc.
Sign in to watch- Ticker
- PMN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- Operating
- Phone
- +1 416-847-6898
- Business address
- SUITE 200, 1920 YONGE STREET, TORONTO, Ontario, Canada, M4S 3E2
- Former names
- AMORFIX LIFE SCIENCES LTD
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 200,000 shares at an average $1.28 ($255,750)
- 4 Open-market buy 10% owner bought 93,223 shares at an average $1.25 ($116,880)
- 4 Open-market buy Director bought 10,000 shares at $1.25 ($12,492)
- 4 Open-market buy 10% owner bought 465,116 shares
- 4 Open-market buy 10% owner bought 465,116 shares
- 4 Open-market buy 10% owner bought 697,674 shares
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Executive Officer acquired 53,192 shares (grant or award)
- 4 Grant or award Director acquired 11,000 shares (grant or award)
Page 4 of 6 · 108 filings